| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d0446a5bd77c7da68216fc2e3f05d48 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0603
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0659
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0651 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0618
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0601
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-067 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06 |
| filingDate |
2016-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5750b195452ea37a9675bc9dadf2d83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4627aca283e0465ea2da9bb48ba47da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8adccad37a963fc1e1263f53a4fb0cb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8772ff03cfbdf4645abc45a4d658d6a2 |
| publicationDate |
2016-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016325115-A1 |
| titleOfInvention |
Low Level Laser Therapy for Alzheimer's Disease |
| abstract |
Methods and systems are provided for delivering visible or infrared biostimulatory energy to bone marrow to subjects having or developing Alzheimer's disease. The radiation is delivered to sites remote from the brain at a dose sufficient to cause stimulated mesenchymal stem cells to appear in the brain and degrade β-amyloid. The energy may be coherent light and can be administered transcutaneously, subcutaneously, or via an intramedullary probe. |
| priorityDate |
2011-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |